Find A Doctor Find A Service Make An Appointment Talk To A Doctor

Health Information Another reason to believe: Health Information At Your Fingertips
printer-friendly version

Generic Aciphex Approved to Treat Chronic Heartburn

FRIDAY, Nov. 8 (HealthDay News) -- The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.

Gastroesophageal reflux disease (GERD), also known as chronic heartburn, is a very common disorder characterized by backward flow of stomach acid to the esophagus. This process could damage tissue in the esophagus, the tube that connects the throat and stomach.

License to produce generic rabeprazole was granted to Dr. Reddy's Laboratories, Kremers Urban Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals and Torrent Pharmaceuticals, the FDA said.

The drug is among a class called proton-pump inhibitors, which are designed to reduce the amount of stomach acid produced. Generic drugs, the FDA stressed, are equivalent to the brand-name versions in strength and quality.

More information

To learn more about GERD, visit Medline Plus.


Copyright ©2013 HealthDay. All rights reserved.


Related Items:

Akron General Medical Center • 1 Akron General Avenue (Formerly 400 Wabash Avenue) • Akron, OH 44307 • 330-344-6000 • 1-800-221-4601    © 2014 Akron General Health System
Find Us on Facebook button


This website is certified by Health On the Net Foundation. Click to verify.

  This site complies with the HONcode standard for trustworthy health information: verify here.